Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals
Author(s) -
Carole Pomier,
Samira Rabaaoui,
JeanFrançois Pouliquen,
Pierre Couppié,
M. El Guedj,
Mathieu Nacher,
Vincent Lacoste,
Eric Wattel,
Mirdad Kazanji,
Franck Mortreux
Publication year - 2012
Publication title -
journal of general virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 167
eISSN - 1465-2099
pISSN - 0022-1317
DOI - 10.1099/vir.0.048348-0
Subject(s) - virology , human t lymphotropic virus , biology , virus , human t lymphotropic virus 1 , cd8 , viral replication , human immunodeficiency virus (hiv) , immunology , antigen , myelopathy , neuroscience , spinal cord , t cell leukemia
Upon antiretroviral therapy (ART) human immunodeficiency virus (HIV)/human T-cell lymphotropic virus type 1 (HTLV-1) co-infected individuals frequently develop neurological disorders through hitherto unknown mechanisms. Here, we show that effective anti-HIV ART increases HTLV-1 proviral load through a polyclonal integration pattern of HTLV-1 in both CD4(+) and CD8(+) T-cell subsets that is reminiscent of that typically associated with HTLV-1-related inflammatory conditions. These data indicate that preventing ART-triggered clonal expansion of HTLV-1-infected cells in co-infected individuals deserves investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom